Skip to main content

Scott M. Dehm

From the FY2024 NIH awards this investigator leads as contact PI. The department is the award's.

FY2024 NIH rank #3,339
  • R01 Holder
  • Translational
  • Multi-Institutional
  • Early Career

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID 9594633Search this ID in NIH RePORTER
ORCID iD
https://orcid.org/0000-0002-7827-5579Verified identifier for this researcher
ScienceDex PI coverage
FY2024 through FY2026Career claims are limited to the years shown.

FY2026 award categories

  • Internal Medicine
  • BIOSTATISTICS & OTHER MATH SCI
  • Pharmacology
  • Pathology

NIH Funding · FY2024

Linked Award Amount
$2.6M
Full award amounts, FY2024
Award Records
5
Records listing this PI
Award-Linked Rank
#3,339
By linked amount among FY2024 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for Scott M. Dehm. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2024 NIH portfolio memberships

No institute-level portfolio release is available for this scientist and fiscal year yet. Existing award history remains unchanged above.

Researcher-associated datasets

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

FY2024 award records by amount

NIH award records listing Scott M. Dehm as a PI. Multi-PI records show the full award amount for context.

  • 5R01CA276269-02R01Co-investigator
    Molecular regulation and expression of Trop-2 in advanced prostate cancer: Identifying optimal therapeutic niches
    $625.9K
    award amount
  • 5R01CA256157-04R01Co-investigator
    Clinical genomic predictive model of first line androgen receptor inhibitor therapy outcomes in men with mCRPC
    $612.2K
    award amount
  • 7R01CA262570-03R01Co-investigator
    Pharmacological Jak2 inhibition to overcome androgen receptor aberrations in prostate cancer
    Thomas Jefferson University · Pharmacology (NIH department code)
    $564.5K
    award amount
  • 5R01CA270539-02R01Contact PI
    Targeting early events in prostate cancer lineage plasticity
    University of Minnesota · Pathology (NIH department code)
    $437.9K
    award amount
  • 5R01CA174777-12R01Contact PI
    AR Gene Rearrangements and AR Signaling in Prostate Cancer
    University of Minnesota · Pathology (NIH department code)
    $383K
    award amount

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2024
    First NIH Award
    University of Minnesota
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    $2M Cumulative Funding
  5. 2024
    Entered Top 50% Nationally
    Ranked #3339
  6. 2024
    Entered Top 25% Nationally
    Ranked #3339
  7. 2025
    $5M Cumulative Funding
  8. 2025
    Multi-Institutional Research
    Awards at 4 institutions
  9. 2025
    R01 Grant Holder
  10. 2026
    $10M Cumulative Funding